Your session is about to expire
← Back to Search
BRONTE Trial Summary
This trial is testing two types of light therapy to see which one works better to treat eczema. The trial will also collect data on participants' eczema severity and use of treatments, as well as blood and skin samples from participants who give permission, to study the mechanisms underlying the disease.
- Atopic Dermatitis
- Skin Diseases
BRONTE Trial Eligibility Criteria
Inclusion CriteriaYou will be eligible if you check “Yes” for the criteria below
BRONTE Trial Timeline
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Awards & Highlights
BRONTE Trial Design
Find a Location
Who is running the clinical trial?
- Your symptoms are severe according to the doctor's evaluation.You have a skin condition called atopic dermatitis as defined by certain medical criteria.Your condition is not improving even after trying different creams or ointments.You have received a specific type of medication called biologic or an experimental treatment within the last 90 days.You have received treatment with light therapy or certain medications that affect your immune system within the last 30 days.You have participated in a clinical trial testing a new treatment for eczema within the past 90 days.
- Group 1: Narrowband UVB
- Group 2: Broadband UVB
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many participants are enrolled in the current clinical trial?
"Indeed, clinicaltrials.gov attests that this research effort is still ongoing and recruiting volunteers. The trial was initially posted on September 27th 2021 and the latest edits were made on March 11th 2022; 120 participants are needed from 1 facility to complete the study."
Is it still feasible to join this research experiment?
"Confirmed, the clinical trial is still enrolling. The original post date was September 27th 2021 and its most recent edit occurred on March 11th 2022 according to information available at clinicaltrials.gov."
Share this study with friends